Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. ≥ 55 years of age.~2. Admitted to hospital with a disease of respiratory system including acute respiratory diseases (e.g., pneumonia, acute bronchitis) or exacerbation of existing respiratory diseases.~3. Anticipated length of hospital stay of at least 3 days.~4. Ability to climb a flight of 10 stairs or walk a city block without the help of another person prior to hospitalization.~5. Able to consume foods and beverages orally.~Exclusion Criteria:~1. Unstable heart failure which requires ICU admission.~2. Severe respiratory disease requiring long-term, continuous oxygen therapy.~3. Diabetes.~4. Impaired renal function.~5. Impaired liver function.~6. Cancer.~7. Hospitalized for two or more days in past 4 weeks.~8. Requires intubation or tube feeding.~9. Expected to be transferred to an advanced care unit.~10. Body mass index of ≥ 40 kg/m2.~11. Active tuberculosis.~12. Ascites or severe edema.~13. Acute Hepatitis or HIV.~14. Disorder of gastrointestinal tract.~15. Dementia;brain metastases, eating disorder, significant neurological, psychiatric disorder, other psychological condition.~16. Medication/dietary supplements/substances that could modulate metabolism or weight.~17. Partial or full artificial lower limb.~18. Allergy or intolerance to any of the ingredients in the study products.~19. Procedure using iodine-based contrast media within 7 days prior to hospitalization; or, anticipated to need procedure using iodine-based contrast media within 3 days after hospital admission.

- Gender: ALL
- Minimum Age: 55 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Experimental Oral Nutrition Supplement (Type: EXPERIMENTAL): Experimental ONS orally Two 8 fl oz servings/day
- No Product (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).